50242-0125 Columvi - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50242-0125

Brand Name:

Columvi

Generic Name:

Glofitamab

Dosage Form Name:

SOLUTION, CONCENTRATE

Administration Route:

Intravenous

Substances:

Name: GLOFITAMAB

Strength: 2.5

Unit: mg/2.5mL

Packages:

Code: 50242-0125-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (50242-125-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE

Effective Date: June 15, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

CD20, CD3

Orphan Drug Designation:

Status:

In Use